Sign In
Buy HSIC
$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein (HSIC) Matches Q4 Earnings Estimates
09:02am, Thursday, 16'th Feb 2023
Henry Schein (HSIC) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Henry Schein sets new $400 million stock repurchase progam
06:39am, Monday, 13'th Feb 2023
Henry Schein Inc. HSIC, +0.37% said Monday that it has authorized a new $400 million share repurchase program. Based on Friday's closing price for the medical product company's stock, the new buyback
Henry Schein: Resiliency Premium Still In Situ
11:19pm, Wednesday, 08'th Feb 2023
Henry Schein's 'resiliency' premium is still well in situ leading into the new year. Shares have caught a bid leading into the firm's full-year numbers.
Henry Schein (HSIC) to Report Q4 Earnings: What's in Store?
12:47pm, Wednesday, 01'st Feb 2023
Henry Schein's (HSIC) dental business is likely to have gained in Q4 from the acquisition of Midway Dental.
Henry Schein to Webcast Fourth Quarter and Full-Year 2022 Conference Call on Thursday, February 16, 2023 at 10:00 a.m. ET
06:30am, Thursday, 19'th Jan 2023
MELVILLE, N.Y.--( BUSINESS WIRE )--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it wi
Henry Schein to Present at Investor Conferences in January 2023
06:30am, Monday, 19'th Dec 2022
MELVILLE, N.Y.--( BUSINESS WIRE )--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the C
Henry Schein's (HSIC) New Tie-Up to Improve Patient Outcome
09:47am, Thursday, 01'st Dec 2022
Henry Schein's (HSIC) recent deal with VideaHealth is expected to aid dentists in proving greater transparency to patients, thus making better treatment recommendations and improving case acceptance.
Henry Schein's (HSIC) New Deal to Improve Patient Outcome
11:17am, Monday, 21'st Nov 2022
Henry Schein's (HSIC) recent deal with Rimidi is expected to aid healthcare professionals in enhancing chronic disease management.
Henry Schein: Long-Term Value Selling Cheap, But Could Get More Attractive
11:25am, Wednesday, 16'th Nov 2022
Henry Schein, Inc. meets the need for continued growth projected into the future. Henry Schein's organic sales are robust across all regions and segments.
Henry Schein to Present at Upcoming Investor Conferences
06:30am, Wednesday, 09'th Nov 2022
MELVILLE, N.Y.
Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q3 2022 Results - Earnings Call Transcript
03:50pm, Tuesday, 01'st Nov 2022
Henry Schein, Inc. (NASDAQ:HSIC ) Q3 2022 Earnings Conference Call November 1, 2022 10:00 AM ET Company Participants Graham Stanley - VP of IR & Strategic Financial Project Officer Stanley Bergman - E
Henry Schein (HSIC) Q3 Earnings In Line, 2022 Sales View Down
01:34pm, Tuesday, 01'st Nov 2022
Severe currency headwinds and lower sales of PPE and COVID-19 test kits affect Henry Schein's (HSIC) top line in Q3.
Henry Schein (HSIC) Surpasses Q3 Earnings Estimates
09:02am, Tuesday, 01'st Nov 2022
Henry Schein (HSIC) delivered earnings and revenue surprises of 0.88% and 4.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Henry Schein (HSIC) to Report Q3 Earnings: What's in Store?
03:48pm, Thursday, 20'th Oct 2022
We expect the Condor Dental buyout to have a beneficial impact on Henry Schein's (HSIC) results in the to-be-reported quarter.
Henry Schein to Present at Investor Conferences in November
06:30am, Thursday, 20'th Oct 2022
MELVILLE, N.Y.
